223 related articles for article (PubMed ID: 26393303)
1. Enobosarm (GTx-024) Modulates Adult Skeletal Muscle Mass Independently of the Androgen Receptor in the Satellite Cell Lineage.
Dubois V; Simitsidellis I; Laurent MR; Jardi F; Saunders PT; Vanderschueren D; Claessens F
Endocrinology; 2015 Dec; 156(12):4522-33. PubMed ID: 26393303
[TBL] [Abstract][Full Text] [Related]
2. A satellite cell-specific knockout of the androgen receptor reveals myostatin as a direct androgen target in skeletal muscle.
Dubois V; Laurent MR; Sinnesael M; Cielen N; Helsen C; Clinckemalie L; Spans L; Gayan-Ramirez G; Deldicque L; Hespel P; Carmeliet G; Vanderschueren D; Claessens F
FASEB J; 2014 Jul; 28(7):2979-94. PubMed ID: 24671706
[TBL] [Abstract][Full Text] [Related]
3. Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats.
Gao W; Reiser PJ; Coss CC; Phelps MA; Kearbey JD; Miller DD; Dalton JT
Endocrinology; 2005 Nov; 146(11):4887-97. PubMed ID: 16099859
[TBL] [Abstract][Full Text] [Related]
4. Selective androgen receptor modulators (SARMs) have specific impacts on the mouse uterus.
Simitsidellis I; Esnal-Zuffiaure A; Kelepouri O; O'Flaherty E; Gibson DA; Saunders PTK
J Endocrinol; 2019 Sep; 242(3):227-239. PubMed ID: 31319382
[TBL] [Abstract][Full Text] [Related]
5. Testosterone and trenbolone enanthate increase mature myostatin protein expression despite increasing skeletal muscle hypertrophy and satellite cell number in rodent muscle.
Dalbo VJ; Roberts MD; Mobley CB; Ballmann C; Kephart WC; Fox CD; Santucci VA; Conover CF; Beggs LA; Balaez A; Hoerr FJ; Yarrow JF; Borst SE; Beck DT
Andrologia; 2017 Apr; 49(3):. PubMed ID: 27246614
[TBL] [Abstract][Full Text] [Related]
6. Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathways.
Narayanan R; Coss CC; Yepuru M; Kearbey JD; Miller DD; Dalton JT
Mol Endocrinol; 2008 Nov; 22(11):2448-65. PubMed ID: 18801930
[TBL] [Abstract][Full Text] [Related]
7. Effects of castration and androgen treatment on androgen-receptor levels in rat skeletal muscles.
Antonio J; Wilson JD; George FW
J Appl Physiol (1985); 1999 Dec; 87(6):2016-9. PubMed ID: 10601143
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor in human skeletal muscle and cultured muscle satellite cells: up-regulation by androgen treatment.
Sinha-Hikim I; Taylor WE; Gonzalez-Cadavid NF; Zheng W; Bhasin S
J Clin Endocrinol Metab; 2004 Oct; 89(10):5245-55. PubMed ID: 15472231
[TBL] [Abstract][Full Text] [Related]
9. Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer.
Dalton JT; Taylor RP; Mohler ML; Steiner MS
Curr Opin Support Palliat Care; 2013 Dec; 7(4):345-51. PubMed ID: 24189892
[TBL] [Abstract][Full Text] [Related]
10. A novel selective androgen receptor modulator (SARM) MK-4541 exerts anti-androgenic activity in the prostate cancer xenograft R-3327G and anabolic activity on skeletal muscle mass & function in castrated mice.
Chisamore MJ; Gentile MA; Dillon GM; Baran M; Gambone C; Riley S; Schmidt A; Flores O; Wilkinson H; Alves SE
J Steroid Biochem Mol Biol; 2016 Oct; 163():88-97. PubMed ID: 27106747
[TBL] [Abstract][Full Text] [Related]
11. Androgens have antiresorptive effects on trabecular disuse osteopenia independent from muscle atrophy.
Laurent MR; Jardà F; Dubois V; Schollaert D; Khalil R; Gielen E; Carmeliet G; Claessens F; Vanderschueren D
Bone; 2016 Dec; 93():33-42. PubMed ID: 27622887
[TBL] [Abstract][Full Text] [Related]
12. Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.
Schmidt A; Meissner RS; Gentile MA; Chisamore MJ; Opas EE; Scafonas A; Cusick TE; Gambone C; Pennypacker B; Hodor P; Perkins JJ; Bai C; Ferraro D; Bettoun DJ; Wilkinson HA; Alves SE; Flores O; Ray WJ
J Steroid Biochem Mol Biol; 2014 Sep; 143():29-39. PubMed ID: 24565564
[TBL] [Abstract][Full Text] [Related]
13. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model.
Venken K; De Gendt K; Boonen S; Ophoff J; Bouillon R; Swinnen JV; Verhoeven G; Vanderschueren D
J Bone Miner Res; 2006 Apr; 21(4):576-85. PubMed ID: 16598378
[TBL] [Abstract][Full Text] [Related]
14. Enhanced evaluation of selective androgen receptor modulators in vivo.
Otto-Duessel M; He M; Adamson TW; Jones JO
Andrology; 2013 Jan; 1(1):29-36. PubMed ID: 23258627
[TBL] [Abstract][Full Text] [Related]
15. A novel synthetic androgen receptor ligand, S42, works as a selective androgen receptor modulator and possesses metabolic effects with little impact on the prostate.
Min L; Yanase T; Tanaka T; Fan W; Nomura M; Kawate H; Okabe T; Takayanagi R; Nawata H
Endocrinology; 2009 Dec; 150(12):5606-16. PubMed ID: 19854864
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor coordinates muscle metabolic and contractile functions.
Ghaibour K; Schuh M; Souali-Crespo S; Chambon C; Charlot A; Rizk J; Rovito D; Rerra AI; Cai Q; Messaddeq N; Zoll J; Duteil D; Metzger D
J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1707-1720. PubMed ID: 37208984
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I.
Aikawa K; Miyawaki T; Hitaka T; Imai YN; Hara T; Miyazaki J; Yamaoka M; Kusaka M; Kanzaki N; Tasaka A; Shiraishi M; Yamamoto S
Bioorg Med Chem; 2015 May; 23(10):2568-78. PubMed ID: 25862209
[TBL] [Abstract][Full Text] [Related]
18. Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor.
Liva SG; Tseng YC; Dauki AM; Sovic MG; Vu T; Henderson SE; Kuo YC; Benedict JA; Zhang X; Remaily BC; Kulp SK; Campbell M; Bekaii-Saab T; Phelps MA; Chen CS; Coss CC
EMBO Mol Med; 2020 Feb; 12(2):e9910. PubMed ID: 31930715
[TBL] [Abstract][Full Text] [Related]
19. Selective androgen receptor modulator activity of a steroidal antiandrogen TSAA-291 and its cofactor recruitment profile.
Hikichi Y; Yamaoka M; Kusaka M; Hara T
Eur J Pharmacol; 2015 Oct; 765():322-31. PubMed ID: 26335395
[TBL] [Abstract][Full Text] [Related]
20. Molecular targets of androgen signaling that characterize skeletal muscle recovery and regeneration.
MacKrell JG; Yaden BC; Bullock H; Chen K; Shetler P; Bryant HU; Krishnan V
Nucl Recept Signal; 2015; 13():e005. PubMed ID: 26457071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
